http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29565283
Outgoing Links
Predicate | Object |
---|---|
contentType | Comment|Journal Article |
endingPage | 353 |
issn | 1744-7631 1472-8222 |
issueIdentifier | 3 |
pageRange | 351-353 |
publicationName | Expert Opinion on Therapeutic Targets |
startingPage | 351 |
bibliographicCitation | Antoniu SA. Crizotinib for EML4-ALK positive lung adenocarcinoma: a hope for the advanced disease? Evaluation of Kwak EL, Bang YJ, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010;363(18):1693-703. Expert Opin Ther Targets. 2011 Mar;15(3):351–3. doi: 10.1517/14728222.2011.550880. PMID: 21208134. |
creator | http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40d8e927677a2a619c5816b256a3469d |
date | 2011-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier | https://doi.org/10.1517/14728222.2011.550880 https://pubmed.ncbi.nlm.nih.gov/21208134 |
isPartOf | https://portal.issn.org/resource/ISSN/1744-7631 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27020 https://portal.issn.org/resource/ISSN/1472-8222 |
language | English |
source | https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title | Crizotinib for EML4-ALK positive lung adenocarcinoma: a hope for the advanced disease? Evaluation of Kwak EL, Bang YJ, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010;363(18):1693-703 |
discussesAsDerivedByTextMining | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11626560 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b23065537a07b03ba7e2ca1197841172 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243164928 |
Total number of triples: 25.